Hypolipidemic activity of phthalimide derivatives. 1. N-Substituted phthalimide derivatives
- 1 November 1979
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 22 (11) , 1399-1402
- https://doi.org/10.1021/jm00197a022
Abstract
The general lipid-lowering action of the N-substituted phthalimide derivatives and the activity of potassium phthalimide, implicates the phthalimide moiety as possessing hypolipidemic activity in [mice and rats]. Compounds containing substituents with chain lengths of 4 Ca or O atoms showed the best hypolipidemic activity in the series tested. Tests involving 1-N-phthalimidobutan-3-one demonstrated a dose-dependent hypolipidemic action free of estrogenic side effects, with no apparent deposition of cholesterol in body organs, and with a high therapeutic index. Further work on the hypolipidemic activity of phthalimido, as well as other imido compounds, is underway.This publication has 6 references indexed in Scilit:
- Cycloalkanones. 9. Comparison of analogs which inhibit cholesterol and fatty acid synthesisJournal of Medicinal Chemistry, 1976
- Di-(2-ethylhexyl)phthalate: An industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rats and miceLife Sciences, 1976
- Effect of dietary di‐2‐ethylhexyl phthalate on lipid biosynthesis in selected tissues from the rat, in vitroLipids, 1976
- A method for sequential quantitative separation and determination of protein, RNA, DNA, lipid, and glycogen from a single rat liver homogenate or from a subcellular fractionAnalytical Biochemistry, 1967
- Evaluation of a recently reported stable liebermann-burchard reagent and its use for the direct determination of serum total cholesterolClinica Chimica Acta; International Journal of Clinical Chemistry, 1964
- A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS1949